Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.

Author: AleksicAlek, BergStacey, BlaneySusan, BomgaarsLisa, SerabeBaruti, ThompsonPatrick

Paper Details 
Original Abstract of the Article :
Valacyclovir, an orally administered pro-drug of acyclovir, is utilized in the therapy of herpes simplex and herpes zoster infections. Little data regarding the pharmacokinetics, safety and tolerability are available for pediatric patients. This report describes acyclovir pharmacokinetics following ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/18561175

データ提供:米国国立医学図書館(NLM)

Valacyclovir and Acyclovir: A Pharmacokinetic Study in Immunocompromised Children

This research delves into the realm of pediatric pharmacokinetics, a fascinating area where we explore how medications behave in the bodies of our youngest patients. This particular study focuses on valacyclovir, a medication commonly used to treat herpes simplex and zoster infections. It seeks to understand how valacyclovir is processed in the bodies of immunocompromised children. The researchers employed a rigorous approach, comparing the pharmacokinetics of valacyclovir to that of intravenous acyclovir, its active component. Furthermore, they investigated the efficacy of valacyclovir in treating active herpes zoster infections in this vulnerable patient population. Their findings provide valuable insights into the pharmacokinetics of valacyclovir in immunocompromised children and contribute to the growing body of knowledge in this critical field.

Understanding Valacyclovir's Journey in Young Bodies

The results of this study shed light on how valacyclovir is absorbed, distributed, metabolized, and eliminated in children with weakened immune systems. This is essential for optimizing treatment strategies and ensuring that patients receive the right dose at the right time.

Implications for Herpes Management in Children

The findings highlight the importance of tailoring treatment approaches to the specific needs of immunocompromised children. This includes careful monitoring of medication levels and adjustments as needed. This research provides valuable data for healthcare professionals who treat herpes infections in children, particularly those with compromised immune systems.

Dr.Camel's Conclusion

The study serves as a valuable guide for doctors to optimize treatment strategies for immunocompromised children with herpes infections. It's fascinating to see how researchers are piecing together the intricate puzzle of how medications work in young bodies, much like desert explorers carefully navigating a vast, complex landscape.

Date :
  1. Date Completed 2008-08-29
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

18561175

DOI: Digital Object Identifier

NIHMS65881

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.